CN103083570B - Traditional Chinese medicine for treating anaphylactoid purpura - Google Patents
Traditional Chinese medicine for treating anaphylactoid purpura Download PDFInfo
- Publication number
- CN103083570B CN103083570B CN201210529297.1A CN201210529297A CN103083570B CN 103083570 B CN103083570 B CN 103083570B CN 201210529297 A CN201210529297 A CN 201210529297A CN 103083570 B CN103083570 B CN 103083570B
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- traditional chinese
- anaphylactoid purpura
- purpura
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 title claims abstract description 17
- 208000031814 IgA Vasculitis Diseases 0.000 title claims abstract description 17
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 title claims abstract description 17
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 9
- 238000011084 recovery Methods 0.000 abstract description 3
- 244000170916 Paeonia officinalis Species 0.000 abstract 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 2
- 244000307697 Agrimonia eupatoria Species 0.000 abstract 1
- 241000931705 Cicada Species 0.000 abstract 1
- 241000555682 Forsythia x intermedia Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000000125 common agrimony Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 14
- 206010037549 Purpura Diseases 0.000 description 10
- 241001672981 Purpura Species 0.000 description 10
- 238000009835 boiling Methods 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 6
- 238000001816 cooling Methods 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010014080 Ecchymosis Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 230000002612 cardiopulmonary effect Effects 0.000 description 2
- 238000009535 clinical urine test Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 206010034754 petechiae Diseases 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 235000020995 raw meat Nutrition 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010068406 Capillaritis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000002956 necrotizing effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of a traditional Chinese medicine, and discloses a traditional Chinese medicine for treating anaphylactoid purpura. The traditional Chinese medicine for treating the anaphylactoid purpura is prepared from cornu bubali, fructus forsythia, root of red-rooted salvia, rhizoma imperatae, liquorice, hairyvein agrimony, cicada slough, radix rehmanniae, radix lithospermi, root bark of the peony tree, root of common peony and radix paeoniae alba. The traditional Chinese medicine for treating the anaphylactoid purpura disclosed by the invention is good in a curative effect, short in treatment course, and high in recovery rate; the recovery rate is 89.2%, and the effective rate is 100%.
Description
Technical field:
The present invention relates to a kind of Chinese medicine for the treatment of anaphylactoid purpura.
Background technology:
Doctor trained in Western medicine thinks, the pathogeny of anaphylactoid purpura is that immune complex damages little blood vessel Capillaritis widely occurs.Necrosing property arteriolitis when serious.Feature is athrombopenic purpura, and petechia, ecchymosis and hematoma performance all can appear in skin and mucosa.Can there be arthralgia, stomachache and digestive tract hemorrhage.Kidney can have brightic change.
The traditional Chinese medical science thinks, primary disease is many, and because of bleeding due to blood-heat, forcing blood is excessive in passages through which vital energy circulates, and channels forms purpura.Patients on long-term is insufficiency of the spleen, sinking of QI of middle-JIAO, failure of the spleen to keep the blood flowing within the vessels, makes blood oozing from the body openings or subcuta neous tissue in meridians.Cold-evil is the important pathogenic factors of primary disease.Cold-evil hinders in meridians, makes skin coagulation of QI-blood, and purpura occurs.By clinical verification, the tcm therapy effect of primary disease is better than doctor trained in Western medicine, and is free from side effects.
Summary of the invention:
The object of the invention is in order to solve the deficiency of above-mentioned technology, provide a kind of good effect, short treating period, cure rate high, can effectively treat the Chinese medicine of anaphylactoid purpura.
For achieving the above object, treat a Chinese medicine for anaphylactoid purpura, it is characterized in that it is comprised of the material medicine proportioning of following weight: Cornu Bubali 30-35g, Fructus Forsythiae 30-35g, Radix Salviae Miltiorrhizae 40-45g, Rhizoma Imperatae 30-35g, Radix Glycyrrhizae 10-15g, Herba Agrimoniae 20-25g, Periostracum Cicadae 30-35g, Radix Rehmanniae 30-35g, Radix Arnebiae (Radix Lithospermi) 10-15g, Cortex Moutan 10-15g, Radix Paeoniae Rubra 15-20g, Radix Paeoniae Alba 30-35g.
Pharmacology analysis:
Chinese medicine of the present invention: Cornu Bubali, bitter cold.GUIXIN Liver Channel.Heat-clearing and toxic substances removing, removing heat from blood arresting convulsion.Fructus Forsythiae, hardship, is slightly cold.Enter heart small intestine meridian.Heat-clearing and toxic substances removing, the eliminating stagnation of relieving inflammation or internal heat.Fructus Forsythiae, containing abundant VP, can strengthen the fine and close power of blood capillary, therefore hemorrhage, the subcutaneous hemorrhage of capillary rupture (as purpura) is had to preventive and therapeutic effect.Radix Salviae Miltiorrhizae, hardship, is slightly cold.Enter conscience warp.Blood circulation and promoting silt, relieving restlessness is calmed the nerves, reducing swelling and alleviating pain.Rhizoma Imperatae, sweet cold.Enter cardiopulmonary stomach urinary bladder channel.Clearing away heat and promoting production of body fluid, clearing away heat and cooling blood, inducing diuresis to remove edema.Radix Glycyrrhizae, sweet flat.Enter taste cardiopulmonary warp.Invigorating the spleen and replenishing QI, relieving spasm to stop pain, heat-clearing and toxic substances removing, the mediation property of medicine.Herba Agrimoniae is pained cool.Enter heart taste large intestine channel.Cooling blood for hemostasis, and have strong effect.Periostracum Cicadae, sweet cold.Enter lung Liver Channel.Dispelling wind and heat pathogens, rash is antipruritic.The Radix Rehmanniae, sweetness and bitterness is cold.Enter conscience kidney channel.Heat clearing away YIN nourishing, cooling blood for hemostasis.Radix Arnebiae (Radix Lithospermi), sweet cold.Enter conscience warp.Removing pathogenic heat from blood and toxic substance from the body, rash doctor skin ulcer.Cortex Moutan, toil is slightly cold.Enter conscience kidney channel.Clearing away heat and cooling blood activating blood circulation and dissipating blood stasis.Radix Paeoniae Rubra, hardship, is slightly cold.Enter Liver Channel.Removing heat from blood and promoting blood circulation, stasis-dispelling and pain-killing.The Radix Paeoniae Alba, picric acid is slightly cold.Enter liver spleen channel.The yin fluid astringing of enriching blood, easing the affected liver to relieve pain.All medicines share above, clearing away heat and cooling blood, removing toxic substances, blood circulation and promoting silt.Treatment anaphylactoid purpura curative effect is very good.
Preparation, instructions of taking and consumption: get side of the present invention, first with cold water, soak 1 hour.Be decocted first boiling water Cornu Bovis seu Bubali 2 hours of first pass, after the lower Chinese medicine that is left.Intense fire is fried boiling, and changes slow fire and is fried boiling 30 minutes, leaches 150ml.Second time, intense fire is fried boiling, and changes slow fire and is fried boiling 40 minutes, leaches 150ml.Twice mixing be 300ml altogether.Sooner or later 30 minutes after meal decoction being taken warmly at twice.Period in a medicine diet raw meat is peppery.
Beneficial effect: 1 dose of this medicine one day 10 days is a course for the treatment of, treats altogether 37 routine patients, with the statistics that is as the criterion two courses for the treatment of of taking medicine, cures 33 examples, 4 examples that take a turn for the better, cure rate 89.2%, effective percentage 100%.
The specific embodiment:
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1: a kind of Chinese medicine for the treatment of anaphylactoid purpura, is comprised of the component of the material medicine proportioning of following weight: Cornu Bubali 30-35g, Fructus Forsythiae 30-35g, Radix Salviae Miltiorrhizae 40-45g, Rhizoma Imperatae 30-35g, Radix Glycyrrhizae 10-15g, Herba Agrimoniae 20-25g, Periostracum Cicadae 30-35g, Radix Rehmanniae 30-35g, Radix Arnebiae (Radix Lithospermi) 10-15g, Cortex Moutan 10-15g, Radix Paeoniae Rubra 15-20g, Radix Paeoniae Alba 30-35g.
Embodiment 2: a kind of Chinese medicine for the treatment of anaphylactoid purpura, wherein the preferred weight proportioning of various material medicines is: Cornu Bubali 30-g, Fructus Forsythiae 30g, Radix Salviae Miltiorrhizae 40g, Rhizoma Imperatae 30g, Radix Glycyrrhizae 10g, Herba Agrimoniae 20g, Periostracum Cicadae 30g, Radix Rehmanniae 30g, Radix Arnebiae (Radix Lithospermi) 10g, Cortex Moutan 10g, Radix Paeoniae Rubra 20g, Radix Paeoniae Alba 30g.
Clinical efficacy is summed up:
One, physical data: the traditional Chinese medical science is divided into two types anaphylactoid purpura: 1. blood-heat type: the purpura of skin occurs suddenly, erythra slightly exceeds surface, and erythra can merge mutually in flakes sometimes, sometimes itches, fever of the body, xerostomia, pharyngalgia, also can have arthralgia or stomachache or hematuria etc.Red tongue, yellow and thin fur, thready and rapid pulse or stringy and thready pulse number.2. spleen-deficient: the course of disease is more of a specified duration, Chang Fanfu outbreak.Erythra is purple dark, shallow complexion, and lassitude, light red tongue or have indentation, tongue is white, thready and weak pulse or deep and slow.Chinese medicine of the present invention is applied to clinical for many years, treats altogether 37 routine patients, blood-heat type 35 examples, spleen-deficient 2 examples.Patient takes 1 dose of medicine every day, within 10 days, is a course for the treatment of.Few person takes medicine a course for the treatment of, three courses for the treatment of of many persons.
Two, criterion of therapeutical effect:
Recovery from illness: purpura is all disappeared, and gastrointestinal symptom disappears completely, arthralgia disappears, and urine test is normal.
Effective: purpura is most of to disappear, gastrointestinal symptom basic controlling, arthralgia takes a turn for the better, and urine test is clearly better.
Invalid: after treatment, symptom, sign are without improvement person.
Three, diagnostic criteria: occur petechia and ecchymosis according to skin lesion, that presses does not fade, and platelet count is normal, or merge gastrointestinal tract, during the performance such as joint or kidney, just can diagnose.
Four, method of administration and curative effect: get side of the present invention, first with cold water, soak 1 hour.Be decocted first boiling water Cornu Bovis seu Bubali 2 hours of first pass, after the lower Chinese medicine that is left.Intense fire is fried boiling, and changes slow fire and is fried boiling 30 minutes, leaches 150ml.Second time, intense fire is fried boiling, and changes slow fire and is fried boiling 40 minutes, leaches 150ml.Twice mixing be 300ml altogether.Sooner or later 30 minutes after meal decoction being taken warmly at twice.Period in a medicine diet raw meat is peppery.Medicine 1 dosage of the present invention is adult's amount, and old man, child are cut down according to the circumstance.Curative effect: treat altogether 37 routine patients, with the statistics that is as the criterion two courses for the treatment of of taking medicine, cure 33 examples, 4 examples that take a turn for the better, cure rate 89.2%, effective percentage 100%.
Five, model case:
Case 1: Liu * *, man, 19 years old, student.In July, 2006 is medical.Sudden tormina.On inspection, find two lower limb large area purpuras.The platelet number of having a blood test is again normal.What purpura was pressed does not fade.Red tongue, rapid pulse and strong.Be diagnosed as anaphylactoid purpura, Syndrome Types of TCM is blood-heat type.Take side of the present invention, recover a course for the treatment of.For anti-recurrence, take again 5 doses after drug withdrawal, follow up a case by regular visits to 3 years, recurrence.
Case 2: grandson * *, female, 39 years old, peasant.In May, 2003 is medical.First 5 days because of hematuria lower limb purpura, enters central hospital's diagnosis and treatment.Be diagnosed as anaphylactoid purpura.With penicillin and hormone therapy, curative effect is undesirable.Inspection of the tongue and pulse-taking, be decided to be blood-heat type anaphylactoid purpura when medical.Give side's treatment of the present invention, take medicine a course for the treatment of, the state of an illness is clearly better.For thorough healing, take medicine again two courses for the treatment of, recover.Follow up a case by regular visits to not recurrence in 5 years.
Claims (1)
1. control a Chinese medicine for anaphylactoid purpura, it is characterized in that it is comprised of the material medicine proportioning of following weight: Cornu Bubali 30-35g, Fructus Forsythiae 30-35g, Radix Salviae Miltiorrhizae 40-45g, Rhizoma Imperatae 30-35g, Radix Glycyrrhizae 10-15g, Herba Agrimoniae 20-25g, Periostracum Cicadae 30-35g, Radix Rehmanniae 30-35g, Radix Arnebiae (Radix Lithospermi) 10-15g, Cortex Moutan 10-15g, Radix Paeoniae Rubra 15-20g, Radix Paeoniae Alba 30-35g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210529297.1A CN103083570B (en) | 2012-12-11 | 2012-12-11 | Traditional Chinese medicine for treating anaphylactoid purpura |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210529297.1A CN103083570B (en) | 2012-12-11 | 2012-12-11 | Traditional Chinese medicine for treating anaphylactoid purpura |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103083570A CN103083570A (en) | 2013-05-08 |
| CN103083570B true CN103083570B (en) | 2014-04-16 |
Family
ID=48197048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210529297.1A Active CN103083570B (en) | 2012-12-11 | 2012-12-11 | Traditional Chinese medicine for treating anaphylactoid purpura |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103083570B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103751431A (en) * | 2013-12-20 | 2014-04-30 | 霍山县中医院 | Traditional Chinese medicinal composition for treating anaphylactoid purpura |
| CN104042970A (en) * | 2014-07-06 | 2014-09-17 | 华菊 | Traditional Chinese medicine (TCM) composition for allergic purpura |
| CN104524287A (en) * | 2014-12-25 | 2015-04-22 | 张晓风 | Traditional Chinese medicinal composition for treating anaphylactoid purpura and preparation method of traditional Chinese medicinal composition |
| CN104667020B (en) * | 2015-03-20 | 2018-06-05 | 新乡医学院第一附属医院 | A kind of pharmaceutical composition for treating anaphylactoid purpura and preparation method thereof |
| CN104800440A (en) * | 2015-05-18 | 2015-07-29 | 西宁科进工业设计有限公司 | Traditional Chinese medicine for treating allergic purpura |
| WO2016183785A1 (en) * | 2015-05-18 | 2016-11-24 | 张甘霖 | Traditional chinese medicine for treating allergic purpura |
| CN105477439A (en) * | 2016-01-29 | 2016-04-13 | 周爱妍 | Traditional Chinese medicine preparation for treating simplex type blood-heat type anaphylaxis purpura |
| CN114099585B (en) * | 2022-01-11 | 2024-05-03 | 河南中医药大学 | Traditional Chinese medicine composition for treating allergic purpura and preparation method and application thereof |
| CN116808101B (en) * | 2023-06-30 | 2024-03-08 | 首都儿科研究所附属儿童医院 | Traditional Chinese medicine composition for treating or improving allergic purpura as well as method and application thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101396531A (en) * | 2008-10-09 | 2009-04-01 | 刘运波 | Traditional Chinese medicine for treating allergic purpura |
| CN101785810A (en) * | 2010-01-26 | 2010-07-28 | 张云平 | Traditional Chinese medicine preparation for anaphylactoid purpura treatment |
| CN102429997A (en) * | 2010-09-29 | 2012-05-02 | 刘娜 | Traditional Chinese medicine preparation for treating allergic purpura |
| CN102552516A (en) * | 2011-12-23 | 2012-07-11 | 河南科技大学第一附属医院 | Chinese medicinal capsule for treating anaphylactoid purpura and preparation method of same |
| CN102670821A (en) * | 2011-03-17 | 2012-09-19 | 辽宁中医药大学 | Traditional Chinese medicine compound preparation for treating allergic purpura, and preparation method thereof |
| CN102772684A (en) * | 2012-07-16 | 2012-11-14 | 梁艳龙 | Traditional Chinese medicinal preparation for treating allergic purpura |
-
2012
- 2012-12-11 CN CN201210529297.1A patent/CN103083570B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101396531A (en) * | 2008-10-09 | 2009-04-01 | 刘运波 | Traditional Chinese medicine for treating allergic purpura |
| CN101785810A (en) * | 2010-01-26 | 2010-07-28 | 张云平 | Traditional Chinese medicine preparation for anaphylactoid purpura treatment |
| CN102429997A (en) * | 2010-09-29 | 2012-05-02 | 刘娜 | Traditional Chinese medicine preparation for treating allergic purpura |
| CN102670821A (en) * | 2011-03-17 | 2012-09-19 | 辽宁中医药大学 | Traditional Chinese medicine compound preparation for treating allergic purpura, and preparation method thereof |
| CN102552516A (en) * | 2011-12-23 | 2012-07-11 | 河南科技大学第一附属医院 | Chinese medicinal capsule for treating anaphylactoid purpura and preparation method of same |
| CN102772684A (en) * | 2012-07-16 | 2012-11-14 | 梁艳龙 | Traditional Chinese medicinal preparation for treating allergic purpura |
Non-Patent Citations (6)
| Title |
|---|
| 中西医结合治疗小儿过敏性紫癜64例;朱生全等;《陕西中医》;20001231;第21卷(第08期);第339页 * |
| 朱生全等.中西医结合治疗小儿过敏性紫癜64例.《陕西中医》.2000,第21卷(第08期), |
| 辨证施治小儿过敏性紫癜12例;陈平;《山东医药》;19931231;第33卷(第01期);第63-64页 * |
| 郑强.重用连翘治疗过敏性紫癜30例.《陕西中医》.1994,第15卷(第06期), |
| 重用连翘治疗过敏性紫癜30例;郑强;《陕西中医》;19941231;第15卷(第06期);第250页 * |
| 陈平.辨证施治小儿过敏性紫癜12例.《山东医药》.1993,第33卷(第01期), |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103083570A (en) | 2013-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103083570B (en) | Traditional Chinese medicine for treating anaphylactoid purpura | |
| CN103705843A (en) | Medicine for treating stomach diseases | |
| CN102671054A (en) | Traditional Chinese medicine composition for treating thrombophlebitis | |
| CN102600394A (en) | Traditional Chinese medicine for treating radiodermatitis | |
| CN102423376A (en) | Traditional Chinese medicine for treating erysipelas | |
| CN103251758B (en) | Traditional Chinese medicine preparation for treating erysipelas | |
| CN102670768A (en) | Traditional Chinese medicine for treating acute appendicitis | |
| CN104958418A (en) | Traditional Chinese herbal medicine ointment for treating burns and scalds | |
| CN104338039A (en) | Traditional Chinese medicine for treating chronic urinary tract infection | |
| CN101085302B (en) | Apply externally ointment for treating hyperplasia of mammary glands | |
| CN103083616B (en) | Traditional Chinese medicine for treating ovarian cyst | |
| CN103083617B (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
| CN102178908A (en) | Preparation method of traditional Chinese medicine for treating over fatigue cold injury | |
| CN104547748A (en) | Anti-acne drug and preparation method thereof | |
| CN101129975A (en) | Externally applied traditional Chinese medicine ointment for treating gland hyperplasia | |
| CN103845580A (en) | Traditional Chinese medicine composition for treating allergic rhinitis | |
| CN103393822A (en) | Drug for treating toothache and preparation method thereof | |
| CN103316239A (en) | Traditional Chinese medicine for treating anaphylactoid purpura | |
| CN105944059A (en) | Traditional Chinese medicine composition for treating gastropathy | |
| CN102188679A (en) | Method for preparing Chinese medicine for treating qi-blood infirmity frostbite | |
| CN104547553A (en) | Traditional Chinese medicine for treating nervous endocrine disorder | |
| CN103656050A (en) | Traditional Chinese medicine ointment for treating mammary gland hyperplasia and preparation method thereof | |
| CN102772620B (en) | Medicine for inhibiting recurrence of cancer after surgery | |
| CN102614482B (en) | Chinese medicine for curing chronic colitis | |
| CN106389598A (en) | Traditional Chinese medicine composition for curing purpura |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: WANG LIHUA Free format text: FORMER OWNER: SONG XIEKAN Effective date: 20141229 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 264411 WEIHAI, SHANDONG PROVINCE TO: 637400 NANCHONG, SICHUAN PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20141229 Address after: 637400 Langzhong city of Sichuan province Shou Shan Si Street No. 8 4 Building 2 unit 2 Building No. 2 Patentee after: Wang Lihua Address before: 264411, Weihai, Shandong Province, Wendeng City, big water town, Southwest Village, No. 678 Patentee before: Song Xiekan |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20151204 Address after: 225500 No. 1 Su Zhong Road, Jiangyan District, Jiangsu, Taizhou Patentee after: JIANGSU SUZHONG PHARMACEUTICAL GROUP Co.,Ltd. Address before: 637400 Langzhong city of Sichuan province Shou Shan Si Street No. 8 4 Building 2 unit 2 Building No. 2 Patentee before: Wang Lihua |
|
| CP01 | Change in the name or title of a patent holder |
Address after: No.1 Suzhong Road, Jiangyan District, Taizhou City, Jiangsu Province 225500 Patentee after: Suzhong Pharmaceutical Group Co.,Ltd. Address before: No.1 Suzhong Road, Jiangyan District, Taizhou City, Jiangsu Province 225500 Patentee before: JIANGSU SUZHONG PHARMACEUTICAL GROUP Co.,Ltd. |
|
| CP01 | Change in the name or title of a patent holder |